載入中
Sintx Technologies, Inc. is an advanced materials enterprise dedicated to researching, developing, and commercializing medical devices crafted from silicon nitride. These innovative products serve biomedical, industrial, and antipathogenic uses, primarily marketed across the United States. Its diverse portfolio includes solid and porous silicon nitride, silicon nitride powder, and specialized coating products, along with advanced silicon nitride composite materials and polyetherketoneketone. Established in 1996, this company, once known as Amedica Corporation, has its corporate headquarters situated in Salt Lake City, Utah.
前收盤價
US$2.11
US$0.00 · 0.00%
盤中時間採用ET。市場資料可能有所延遲。
Sintx Technologies, Inc. is an advanced materials enterprise dedicated to researching, developing, and commercializing medical devices crafted from silicon nitride. These innovative products serve biomedical, industrial, and antipathogenic uses, primarily marketed across the United States. Its diverse portfolio includes solid and porous silicon nitride, silicon nitride powder, and specialized coating products, along with advanced silicon nitride composite materials and polyetherketoneketone. Established in 1996, this company, once known as Amedica Corporation, has its corporate headquarters situated in Salt Lake City, Utah.
日內區間
目前US$2.11
52週區間
目前US$2.11
盤中時間採用ET。市場資料可能有所延遲。
Sintx Technologies, Inc. is an advanced materials enterprise dedicated to researching, developing, and commercializing medical devices crafted from silicon nitride. These innovative products serve biomedical, industrial, and antipathogenic uses, primarily marketed across the United States. Its diverse portfolio includes solid and porous silicon nitride, silicon nitride powder, and specialized coating products, along with advanced silicon nitride composite materials and polyetherketoneketone. Established in 1996, this company, once known as Amedica Corporation, has its corporate headquarters situated in Salt Lake City, Utah.
日內區間
目前US$2.11
52週區間
目前US$2.11
獲利能力占已公布營收的百分比。
營收
營業利益
淨利
| 項目（USD） | 2025會計年度 | 2024會計年度 | 2023會計年度 | 2022會計年度 | 2021會計年度 |
|---|---|---|---|---|---|
| 營收 | 101.8萬 USD | 124.6萬 USD | 262.7萬 USD | 60.1萬 USD | 60.6萬 USD |
| 銷貨成本 | 121.9萬 USD | 81.1萬 USD | 78.4萬 USD | 26.5萬 USD | 44.9萬 USD |
| 毛利 | −20.1萬 USD | 43.5萬 USD | 184.3萬 USD | 33.6萬 USD | 15.7萬 USD |
| 研究與開發 | 458.7萬 USD | 520.1萬 USD | 871.3萬 USD | 645萬 USD | 588.6萬 USD |
| 銷售、一般及管理費用 | 643.9萬 USD | 461.1萬 USD | 535.9萬 USD | 532.6萬 USD | 489.1萬 USD |
| 營業費用 | 1052萬 USD | 1448.2萬 USD | 1520.1萬 USD | 1167.1萬 USD | 1077.7萬 USD |
| 利息收入 | 17.5萬 USD | 10.7萬 USD | 13.5萬 USD | 2.3萬 USD | 10.1萬 USD |
| 利息支出 | 5.2萬 USD | 2.9萬 USD | 2000 USD | 1.7萬 USD | 2.5萬 USD |
| 折舊和攤銷 | 66.2萬 USD | 138.4萬 USD | 165.7萬 USD | 96.3萬 USD | 65萬 USD |
| 營業利益 | −1072.1萬 USD | −1404.7萬 USD | −1335.8萬 USD | −1133.5萬 USD | −1062萬 USD |
| 淨利 | −1708.3萬 USD | −1102.4萬 USD | −825.9萬 USD | −1203.9萬 USD | −930.9萬 USD |
公司資料更新於 2026年10月11日。
第三方分析師預期可能變動，並非 GoAI 建議。
評級樣本有限，僅3項
| 行動 | 生效日期 | 詳情 | 記錄日期 | 付款日期 |
|---|---|---|---|---|
股票分割 | 2024年5月28日 | 1:200 | — | — |
股票分割 | 2022年12月20日 | 1:100 | — | — |
股票分割 | 2019年7月29日 | 1:30 | — | — |
股票分割 | 2017年11月10日 | 1:12 | — | — |
股票分割 | 2016年1月25日 | 1:15 | — | — |
已生效 2024年5月28日
1:200
已生效 2022年12月20日
1:100
已生效 2019年7月29日
1:30
已生效 2017年11月10日
1:12
已生效 2016年1月25日
1:15
報告持有此股票曝險的交易所交易基金。
AI 生成內容及延遲市場資料僅供資訊與教育用途，不構成投資建議。
